Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Blood group A antigen hexaose type 2 | A Antigen Hexaose Type 2 is a antigen hexaose type 2 employed in the research of autoimmune disorders such as rheumatoid arthritand psoriasis. Synonyms: GalNAca-3(fuca-2)Galb-4GlcNAcb-3Galb-4Glc. CAS No. 30461-82-6. Molecular formula: C40H68N2O30. Mole weight: 1056.96. |  |
| Blood Group B antigen hexaose | Blood Group B antigen hexaose is a compound commonly for the research of various diseases playing a vital role in the field of immunology, used in detecting and determining the presence of the B antigen on red blood cells. Synonyms: Gal-a-1,3(Fuc-a-1,2)Gal-b-1,4GlcNAc-b-1,3Gal-b-1,4Glc. Molecular formula: C38H65NO30. Mole weight: 1015.93. | |
| Difucosyllacto-N-hexaose (a) | Difucosyllacto-N-hexaose (a) is an indispensable molecule widely employed in the biomedical sector due to its inherent therapeutic attributes. Its efficacy in tackling various ailments such as cancer and autoimmune disorders has been established through rigorous examination. Notably, this compound serves as an unrivaled asset in precise medical examinations elucidating individualized pharmacological targets. Synonyms: DFLNH (a); Difucosyl-para-lacto-N-neo-hexaose; β-Gal-(1-4)[α-Fuc-(1-3)]-β-GlcNAc-(1-3)-β-Gal-(1-4)[α-Fuc(1-3)]-β-GlcNAc(1-3)-β-Gal-(1-4)-Glc; Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)Glc; O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose; DF-pLNnH; Difucosyl p-lacto-N-neohexaose; Difucosyl-para-lacto-N-neohexaose. Grade: ≥90%. CAS No. 64396-27-6. Molecular formula: C52H88N2O39. Mole weight: 1365.25. | |
| Difucosyllacto-N-hexaose b | Difucosyllacto-N-hexaose b is an extraordinary biomedical marvel meticulously designed to study a plethora of ailments like microbial infections instigated by select bacteria and viruses. Synonyms: DFLNH (b); Difuco-lacto-N-hexaose; Difucosyllacto-N-neohexaose II; D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1->3)-O-[β-D-galactopyranosyl-(1->4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1->6)-O-[O-6-deoxy-α-L-galactopyranosyl-(1->4)-O-[β-D-ga lactopyranosyl-(1->3)]-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1->3)]-O-β-D-galactopyranosyl-(1->4)-; O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→6)-O-[O-6-deoxy-α-L-galactopyranosyl-(1→4)-O-[β-D-galactopyranosyl-(1→3)]-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)]-O-β-D-galactopyranosyl-(1→4)-D-glucose; DFLNH B; DFSLNnH; Difucosyl-lacto-N-hexaose II. Grade: ≥95%. CAS No. 98359-76-3. Molecular formula: C52H88N2O39. Mole weight: 1365.25. | |
| Difucosyllacto-N-hexaose (c) | Difucosyllacto-N-hexaose (c) is a compound skillfully targeting select proteins implicated in cellular adhesion, rendering it extensively employed in the research of anti-inflammatory and anti-infective therapeutic advancements. Synonyms: DFLNH (c); Lewis b octasaccharide branched; O-6-Deoxy-alpha-L-galactopyranosyl-(1→2)-O-beta-D-galactopyranosyl-(1→3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)-O-[O-beta-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→6)]-O-beta-D-galactopyranosyl-(1→4)-D-glucose. Grade: 95%. CAS No. 443361-17-9. Molecular formula: C52H88N2O39. Mole weight: 1365.25. | |
| Difucosyl-para-lacto-N-hexaose-APD-HSA | Difucosyl-para-lacto-N-hexaose-APD-HSA. | |
| Difucosyl-para-lacto-N-hexaose I | Difucosyl-para-lacto-N-hexaose I is an indispensable constituent forged from fucosylated oligosaccharides. Displaying an extraordinary configuration, Difucosyl-para-lacto-N-hexaose I finds applicability in the research of sundry afflictions such as cancer and autoimmune maladies. Synonyms: Lewis b octasaccharide linear; DFpLNH. Molecular formula: C53H91N2O38. Mole weight: 1364.28. | |
| Difucosyl-para-lacto-N-hexaose II | Difucosyl-para-lacto-N-hexaose II, a highly promising biomedicine, stands at the forefront of diverse disease treatments. Showcasing its prowess, this potent compound exhibits immense potential in honing in on selective receptors implicated in cancer metastasis, thus paving the way for the advancement of targeted therapeutic approaches. Moreover, its indispensability arises from its pivotal role in modulating immune responses, offering efficacious treatment to autoimmune maladies. Synonyms: DFpLNH II; Dimeric Lewis a-Lewis x octasaccharide linear; O-6-Deoxy-α-L-galactopyranosyl-(1→4)-O-[β-D-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose; Difucosyl-p-lacto-N-hexaose; Difucosyl-para-lacto-N-hexaose; Difucosyl-para-N-hexaose. Grade: ≥95%. CAS No. 64309-01-9. Molecular formula: C52H88N2O39. Mole weight: 1365.25. | |
| Difucosyl-para-lacto-N-hexaose III | Difucosyl-para-lacto-N-hexaose III. | |
| Disialyllacto-N-hexaose I | Disialyllacto-N-hexaose I is a profound biomedical compound, playing a pivotal role in the research of diverse ailments by effectively targeting a spectrum of receptors linked to both malignant neoplasms and infection. Synonyms: DSLNH-I; O-(N-Acetyl-a-neuraminosyl)-(2→3)-O-b-D-galactopyranosyl-(1→3)-O-2-acetamido-2-deoxy-b-D-glucopyranosyl-(1→3)-O-[O-(N-acetyl-a-neuraminosyl)-(2→6)-O-b-D-galactopyranosyl-(1→4)-2-acetamido)-2-deoxy-b-D-glucopyranosyl-(1→6)]-O-b-D-galactopyranosyl-(1→4)-D-glucose. CAS No. 137636-98-7. Molecular formula: C62H102N4O47. Mole weight: 1655.47. | |
| Disialyl, monofucosyllacto-N-hexaose | Disialyl, monofucosyllacto-N-hexaose is a biomedical product, exhibiting remarkable ability to selectively target and impede the proliferation of malignant cells. Furthermore, its utilization as a tool for investigating glycobiological phenomena and cellular surface interactions enhances our understanding of intricate biological mechanisms. Synonyms: DSFLNH; Disialyllactomonofucosyl-N-hexaose; O-(N-Acetyl-α-neuraminosyl)-(2→6)-O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-Glucopyranosyl-(1→6)-O-[O-(N-acetyl-α-neuraminosyl)-(2→3)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)]-O-β-D-galactopyranosyl-(1→4)-D-glucose. CAS No. 263916-84-3. Molecular formula: C68H112N4O51. Mole weight: 1801.61. | |
| Fucosyl-para-lacto-N-hexaose I | Fucosyl-para-lacto-N-hexaose I, a remarkable compound, serves as a pivotal asset within the biomedical realm. Embracing its inherent medicinal prowess, this extraordinary substance exhibits unparalleled capabilities in combatting a myriad of maladies. Synonyms: MFpLNH IV; Fucosyl-p-lacto-N-hexaose IV; Fucosyl-para-lacto-N-hexaoseIV; β-Gal-(1→3)-β-GlcNAc-(1→3)-β-Gal-(1-4)(α-Fuc-[1→3])-β-GlcNAc-(1→3)-β-Gal-(1→4)-Glc; O-β-D-Galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose; F-pLNH; FpLNH-I; Fucosyl-para-lacto N-hexaose; Fucosyl-para-lacto-N-hexaose; Monofucosyl-para-lacto-N-hexaose IV; III3-Fucosyl-p-lacto-N-hexaose; Para-Lacto-N-fucosylhexaose. Grade: ≥95%. CAS No. 115236-58-3. Molecular formula: C46H78N2O35. Mole weight: 1219.12. | |
| Globohexaosylceramide | Globohexaosylceramide is an intricate carbohydrate-derived compound, finding its application as a research tool in unraveling mysteries pertaining to specific ailments such as cancer. Synonyms: Ceramide, 1-O-[O-6-deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl-(1→3)-O-α-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]-; Ganglioside GA3, O-6-deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl-(1→3)-O-α-D-galactopyranosyl-(1→4B)-; Globo H; Globo-H hexaose. Grade: 90%. CAS No. 77538-31-9. | |
| Globo-H hexasaccharide-sp-biotin | Globo-H Hexasaccharide-sp-biotin is a biomedical product used to aid in the treatment and detection of certain types of cancer, particularly breast and ovarian cancer. It acts as a therapeutic agent by targeting and delivering drugs to cancer cells while sparing healthy cells. Additionally, it serves as a diagnostic tool by enabling the visualization of cancer cells through a process known as immunoassay. Synonyms: Globo-H Hexaose-b-NAc-Spacer-biotin. Grade: 90%. Molecular formula: C61H102N8O35S. Mole weight: 1539.56. | |
| lacto-N-biosidase | The enzyme from Streptomyces specifically hydrolyses the terminal lacto-N-biosyl residue (β-D-Gal-(1?3)-D-GlcNAc) from the non-reducing end of oligosaccharides with the structure β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?R). Lacto-N-hexaose (β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is hydrolysed to form first lacto-N-tetraose plus lacto-N-biose, with the subsequent formation of lactose. Oligosaccharides in which the non-reducing terminal Gal or the penultimate GlcNAc are replaced by fucose or sialic acid are not substrates. Asialo GM1 tetraose (β-D-Gal-(1?3)-β-D-GalNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is hydrolysed very slowly, but lacto-N-neotetraose (β-D-Gal-(1?4)-β-D-GalNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is not a substrate. Group: Enzymes. Enzyme Commission Number: EC 3.2.1.140. CAS No. 146359-52-6. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3823; lacto-N-biosidase; EC 3.2.1.140; 146359-52-6. Cat No: EXWM-3823. |  |
Our database is helping our users find suppliers everyday.
